454 related articles for article (PubMed ID: 25084733)
41. Effects of the nitric oxide donor molsidomine on the early stages of liver damage in rats with bile duct ligation: a biochemical and immunohistochemical approach.
Oztürk H; Yağmur Y; Buyukbayram H; Dokucu AI; Gurel A
Eur Surg Res; 2002; 34(4):285-90. PubMed ID: 12145554
[TBL] [Abstract][Full Text] [Related]
42. Lipoic acid prevents hepatic and intestinal damage induced by obstruction of the common bile duct in rats.
Somi MH; Kalageychi H; Hajipour B; Musavi G; Khodadadi A; Shokri N; Hashemi R; Bagheri I; Mutab Laleh F
Eur Rev Med Pharmacol Sci; 2013 May; 17(10):1305-10. PubMed ID: 23740441
[TBL] [Abstract][Full Text] [Related]
43. Chronic bile duct obstruction induces changes in plasma and hepatic levels of cytokines and nitric oxide in the rat.
Fernández-Martínez E; Pérez-Alvarez V; Tsutsumi V; Shibayama M; Muriel P
Exp Toxicol Pathol; 2006 Aug; 58(1):49-58. PubMed ID: 16617007
[TBL] [Abstract][Full Text] [Related]
44. Antifibrotic effects of the methanol extract of Polygonum aviculare in fibrotic rats induced by bile duct ligation and scission.
Nan JX; Park EJ; Kim HJ; Ko G; Sohn DH
Biol Pharm Bull; 2000 Feb; 23(2):240-3. PubMed ID: 10706393
[TBL] [Abstract][Full Text] [Related]
45. Ethyl acetate fraction of Amomum xanthioides improves bile duct ligation-induced liver fibrosis of rat model via modulation of pro-fibrogenic cytokines.
Kim HG; Han JM; Lee JS; Lee JS; Son CG
Sci Rep; 2015 Sep; 5():14531. PubMed ID: 26412144
[TBL] [Abstract][Full Text] [Related]
46. Aldehyde dehydrogenase-2 activation by Alda-1 decreases necrosis and fibrosis after bile duct ligation in mice.
Wimborne HJ; Takemoto K; Woster PM; Rockey DC; Lemasters JJ; Zhong Z
Free Radic Biol Med; 2019 Dec; 145():136-145. PubMed ID: 31557514
[TBL] [Abstract][Full Text] [Related]
47. Paclitaxel alleviates liver fibrosis induced by bile duct ligation in rats: Role of TGF-β1, IL-10 and c-Myc.
Sharawy MH; Abdel-Rahman N; Megahed N; El-Awady MS
Life Sci; 2018 Oct; 211():245-251. PubMed ID: 30243650
[TBL] [Abstract][Full Text] [Related]
48. Hepatic and systemic effects of rosuvastatin on an experimental model of bile duct ligation in rats.
Olteanu D; Nagy A; Dudea M; Filip A; Muresan A; Catoi C; Mircea PA; Clichici S
J Physiol Pharmacol; 2012 Oct; 63(5):483-96. PubMed ID: 23211302
[TBL] [Abstract][Full Text] [Related]
49. Pomegranate peel extract prevents liver fibrosis in biliary-obstructed rats.
Toklu HZ; Dumlu MU; Sehirli O; Ercan F; Gedik N; Gökmen V; Sener G
J Pharm Pharmacol; 2007 Sep; 59(9):1287-95. PubMed ID: 17939210
[TBL] [Abstract][Full Text] [Related]
50. Effects of Yinchenhao decoction on self-regulation of renin-angiotensin system by targeting angiotensin converting enzyme 2 in bile duct-ligated rat liver.
Wu L; Zhou PQ; Xie JW; Zhu R; Zhou SC; Wang G; Wu ZX; Hao S
J Huazhong Univ Sci Technolog Med Sci; 2015 Aug; 35(4):519-524. PubMed ID: 26223920
[TBL] [Abstract][Full Text] [Related]
51. Successively postadministered melatonin prevents disruption of hepatic antioxidant status in rats with bile duct ligation.
Ohta Y; Imai Y; Matsura T; Yamada K; Tokunaga K
J Pineal Res; 2005 Nov; 39(4):367-74. PubMed ID: 16207292
[TBL] [Abstract][Full Text] [Related]
52. The efficiency of CAPE on retardation of hepatic fibrosis in biliary obstructed rats.
Tomur A; Kanter M; Gurel A; Erboga M
J Mol Histol; 2011 Oct; 42(5):451-8. PubMed ID: 21822612
[TBL] [Abstract][Full Text] [Related]
53. Antifibrotic effect of N-acetyl-seryl-aspartyl-lysyl-proline on bile duct ligation induced liver fibrosis in rats.
Zhang L; Xu LM; Chen YW; Ni QW; Zhou M; Qu CY; Zhang Y
World J Gastroenterol; 2012 Oct; 18(37):5283-8. PubMed ID: 23066324
[TBL] [Abstract][Full Text] [Related]
54. Dithiothreitol supplementation mitigates hepatic and renal injury in bile duct ligated mice: Potential application in the treatment of cholestasis-associated complications.
Heidari R; Ghanbarinejad V; Mohammadi H; Ahmadi A; Esfandiari A; Azarpira N; Niknahad H
Biomed Pharmacother; 2018 Mar; 99():1022-1032. PubMed ID: 29307496
[TBL] [Abstract][Full Text] [Related]
55. Effects of methylene blue in reducing cholestatic oxidative stress and hepatic damage after bile-duct ligation in rats.
Aksu B; Umit H; Kanter M; Guzel A; Aktas C; Civelek S; Uzun H
Acta Histochem; 2010 May; 112(3):259-69. PubMed ID: 19217652
[TBL] [Abstract][Full Text] [Related]
56. Modulation of the cannabinoid receptors by andrographolide attenuates hepatic apoptosis following bile duct ligation in rats with fibrosis.
Lee TY; Lee KC; Chang HH
Apoptosis; 2010 Aug; 15(8):904-14. PubMed ID: 20446039
[TBL] [Abstract][Full Text] [Related]
57. Hepatoprotective and antioxidant activity of Phaseolus trilobus, Ait on bile duct ligation induced liver fibrosis in rats.
Fursule RA; Patil SD
J Ethnopharmacol; 2010 Jun; 129(3):416-9. PubMed ID: 20430092
[TBL] [Abstract][Full Text] [Related]
58. Sildenafil protects against bile duct ligation induced hepatic fibrosis in rats: Potential role for silent information regulator 1 (SIRT1).
Abd El Motteleb DM; Ibrahim IAAE; Elshazly SM
Toxicol Appl Pharmacol; 2017 Nov; 335():64-71. PubMed ID: 28974454
[TBL] [Abstract][Full Text] [Related]
59. The anti-fibrotic effects of epigallocatechin-3-gallate in bile duct-ligated cholestatic rats and human hepatic stellate LX-2 cells are mediated by the PI3K/Akt/Smad pathway.
Yu DK; Zhang CX; Zhao SS; Zhang SH; Zhang H; Cai SY; Shao RG; He HW
Acta Pharmacol Sin; 2015 Apr; 36(4):473-82. PubMed ID: 25832428
[TBL] [Abstract][Full Text] [Related]
60. Effect of tetrandrine on experimental hepatic fibrosis induced by bile duct ligation and scission in rats.
Park PH; Nan JX; Park EJ; Kang HC; Kim JY; Ko G; Sohn DH
Pharmacol Toxicol; 2000 Dec; 87(6):261-8. PubMed ID: 11140824
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
